These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Zeitoun K; Takayama K; Michael MD; Bulun SE Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254 [TBL] [Abstract][Full Text] [Related]
4. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901 [TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385 [TBL] [Abstract][Full Text] [Related]
6. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826 [TBL] [Abstract][Full Text] [Related]
7. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. Bulun SE; Economos K; Miller D; Simpson ER J Clin Endocrinol Metab; 1994 Dec; 79(6):1831-4. PubMed ID: 7989490 [TBL] [Abstract][Full Text] [Related]
8. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. Bulun SE; Simpson ER; Word RA J Clin Endocrinol Metab; 1994 Mar; 78(3):736-43. PubMed ID: 8126151 [TBL] [Abstract][Full Text] [Related]
9. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235 [TBL] [Abstract][Full Text] [Related]
10. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796 [TBL] [Abstract][Full Text] [Related]
11. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Kitawaki J; Kusuki I; Koshiba H; Tsukamoto K; Honjo H Gynecol Obstet Invest; 1999; 48 Suppl 1():21-8. PubMed ID: 10559661 [TBL] [Abstract][Full Text] [Related]
12. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. Bulun SE; Mahendroo MS; Simpson ER J Clin Endocrinol Metab; 1993 Jun; 76(6):1458-63. PubMed ID: 7684741 [TBL] [Abstract][Full Text] [Related]
13. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Kitawaki J; Noguchi T; Amatsu T; Maeda K; Tsukamoto K; Yamamoto T; Fushiki S; Osawa Y; Honjo H Biol Reprod; 1997 Sep; 57(3):514-9. PubMed ID: 9282984 [TBL] [Abstract][Full Text] [Related]
14. Absence of aromatase protein and mRNA expression in endometriosis. Colette S; Lousse JC; Defrère S; Curaba M; Heilier JF; Van Langendonckt A; Mestdagt M; Foidart JM; Loumaye E; Donnez J Hum Reprod; 2009 Sep; 24(9):2133-41. PubMed ID: 19493871 [TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR. Agarwal VR; Bulun SE; Simpson ER Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317 [TBL] [Abstract][Full Text] [Related]
16. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205 [TBL] [Abstract][Full Text] [Related]
17. Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues. Yang HJ; Shozu M; Murakami K; Sumitani H; Segawa T; Kasai T; Inoue M J Clin Endocrinol Metab; 2002 Aug; 87(8):3745-53. PubMed ID: 12161505 [TBL] [Abstract][Full Text] [Related]
18. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Means GD; Kilgore MW; Mahendroo MS; Mendelson CR; Simpson ER Mol Endocrinol; 1991 Dec; 5(12):2005-13. PubMed ID: 1724289 [TBL] [Abstract][Full Text] [Related]
19. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Velasco I; Rueda J; Acién P Mol Hum Reprod; 2006 Jun; 12(6):377-81. PubMed ID: 16641167 [TBL] [Abstract][Full Text] [Related]
20. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]